NASDAQ · Healthcare · Biotechnology
CAMP4 Therapeutics Corporation
CAMP
CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. CEO Joshua Mandel-Brehm · Market cap $232.2M.
$3.70
-0.14 · -3.65%
52w hi $7.7552w lo $2.86
Off 52w high 51.0%
64
NOTABLE
Current InsiderScore
Corp · 90d
3
2 buys · 1 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
1
0 strong · 1 notable
Analyst consensus
Strong Buy
Avg PT $10.75
Section 01
Recent Form 4 filings
8 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Aug 31 | Kelly Gold | Chief Financial Officer | Buy | 10,000 | $3.96 | +$40K | 64 |
| Aug 27 | Andrew J. Schwab | Sell | 400,000 | $4.04 | −$1.62M | 28 | |
| Aug 03 | Richard A Young | Buy | 16,378 | $1.65 | +$27K | 34 | |
| Sep 11 | Amir Nashat | Buy | 1,221,721 | $1.53 | +$1.87M | 83 | |
| Sep 11 | Polaris Management Co. VII, L.L.C. | Buy | 1,221,721 | $1.53 | +$1.87M | 83 | |
| Sep 11 | Amir Nashat | Buy | 85,468 | $1.53 | +$131K | 77 | |
| Sep 11 | Polaris Management Co. VII, L.L.C. | Buy | 85,468 | $1.53 | +$131K | 77 | |
| Sep 11 | 5AM Partners VI, LLC | Buy | 2,941,176 | $1.53 | +$4.50M | 73 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
NovDecJanFebMarAprMayJunJulAugSepOct